Kidney Transplant

Clinical Trials

Below is a list of Kidney Transplant clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

Comparison of Different Doses of Cellcept in Combination with Tacrolimus, Cyclosporine and Corticosteroids in New Kidney Transplant Recipients
This research study is being done to study the effects (good and bad) of measuring the amount of CellCept in your blood to determine your CellCept dose versus taking a fixed dose of CellCept, without measuring the amount in your blood. CellCept is one of the three immunosuppressant drugs (drugs that suppress your immune system), which you will take after your kidney transplant. You will also take cyclosporine or tacrolimus and corticosteroids.
Read more

Comparison of Tacrolimus and Sirolmius Immunosuppression in Kidney Transplant Patients
The research study is being done to find out which treatment Tacrolimus or Sirolimus leads to better long-term kidney function. At the time of transplant or about 1 month later patients will be placed in one of two groups, Tacrolimus or Sirolimus
Read more

Examination of the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients
This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibody can cause damage to kidneys after they are transplanted. The study will look at the impact of immunosuppression on antibody production by these cells.
Read more

Folic Acid for Vascular Outcome Reduction in Transplantation
This research study is a multi-center trial to determine whether high doses of folic acid and vitamins B6 and B12 can reduce the rate of cardiovascular disease in renal transplant patients by lowering homocysteine levels.
Read more

Long-Term Deterioration of Kidney Transplants
The research study is being done to create a kidney transplant database with information from many transplant centers for the purpose of studying ways to help improve transplant outcomes and the care of transplant recipients. It is also being done to learn why kidney transplant recipients have worsening of their kidney function, and whether there are specific findings that could result in future treatments.
Read more